Mead Johnson Nutrition Announces Pricing of Notes Offering
- $500 million principal amount of 3.50% Notes due 2014 priced at 99.552% of the principal amount,
- $700 million principal amount of 4.90% Notes due 2019 priced at 99.649% of the principal amount, and
- $300 million principal amount of 5.90% Notes due 2039 priced at 99.973% of the principal amount.
Proceeds from the offering are intended to be used to repay debt owed to
a subsidiary of
The notes were offered in a transaction exempt from registration
pursuant to Rule 144A and Regulation S under the Securities Act of 1933,
as amended (the Securities Act). The notes have not been registered
under the Securities Act, and may not be offered or sold in
This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.
Forward-Looking Statements
Certain disclosures in this news release are “forward-looking
statements” within the federal securities laws concerning Mead Johnson’s
note offering. These statements, which are identified by words such as
“expects,” “intends” and “believes,” involve certain risks and
uncertainties that may cause actual results to differ materially from
expectations as of the date of this news release. The company undertakes
no obligation to publicly update any forward-looking statement, whether
as a result of new information, future events or otherwise. These
statements are subject to risks and uncertainties, including without
limitation, general market conditions, the market for the company’s
securities, the performance of the company’s business and other risks
detailed in the company’s filings with the
Source:
Mead Johnson Nutrition Company
Investors:
Kathryn Chieger, 847-832-2419
kathryn.chieger@mjn.com
or
Media:
Christopher
Perille, 847-832-2178
chris.perille@mjn.com
10/30/2009